Related references
Note: Only part of the references are listed.The Challenge of Classifying Metastatic Cell Properties by Molecular Profiling Exemplified with Cutaneous Melanoma Cells and Their Cerebral Metastasis from Patient Derived Mouse Xenografts
Benjamin Neuditschko et al.
MOLECULAR & CELLULAR PROTEOMICS (2020)
RIG-I activation is critical for responsiveness to checkpoint blockade
Simon Heidegger et al.
SCIENCE IMMUNOLOGY (2019)
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade
Jeffrey J. Ishizuka et al.
NATURE (2019)
RIG-I and Other RNA Sensors in Antiviral Immunity
Kwan T. Chow et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion
Yiting Wang et al.
FRONTIERS IN PHARMACOLOGY (2018)
Interleukin-6 and Interferon-α Signaling via JAK1STAT Differentially Regulate Oncolytic versus Cytoprotective Antiviral States
Oded Danziger et al.
FRONTIERS IN IMMUNOLOGY (2018)
Stromal CD38 regulates outgrowth of primary melanoma and generation of spontaneous metastasis
Bar Ben Baruch et al.
Oncotarget (2018)
T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection
Jonathan A. Trujillo et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
Nicholas McGranahan et al.
CELL (2017)
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
Jianjun Gao et al.
CELL (2016)
Combined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infection
Oded Danziger et al.
ONCOTARGET (2016)
Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
Yuliya V. Katlinskaya et al.
CELL REPORTS (2016)
The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
John J. O'Shea et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses
Katherine B. Chiappinelli et al.
CELL (2015)
Genomic Classification of Cutaneous Melanoma
Rehan Akbani et al.
CELL (2015)
Type I IFN family members: Similarity, differences and interaction
Maria Rosaria Capobianchi et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Metastatic Melanoma Cells Evade Immune Detection by Silencing STAT1
JoDi Lynn Osborn et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
The Chemokine System in Innate Immunity
Caroline L. Sokol et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
Interferon-Stimulated Genes: A Complex Web of Host Defenses
William M. Schneider et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8+ T cells
P. Duewell et al.
CELL DEATH AND DIFFERENTIATION (2014)
Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy
Matthew D. Vesely et al.
RENAISSANCE OF CANCER IMMUNOTHERAPY (2013)
A Polymorphism in IRF4 Affects Human Pigmentation through a Tyrosinase-Dependent MITF/TFAP2A Pathway
Christian Praetorius et al.
CELL (2013)
The antimelanoma activity of the histone deacetylase inhibitor panobinostat (LBH589) is mediated by direct tumor cytotoxicity and increased tumor immunogenicity
David M. Woods et al.
MELANOMA RESEARCH (2013)
Dicodon monitoring of protein synthesis (DiCoMPS) reveals levels of synthesis of a viral protein in single cells
Sima Barhoom et al.
NUCLEIC ACIDS RESEARCH (2013)
Cellular Self-Defense: How Cell-Autonomous Immunity Protects Against Pathogens
Felix Randow et al.
SCIENCE (2013)
Exploiting tumor epigenetics to improve oncolytic virotherapy
Nicole E. Forbes et al.
Frontiers in Genetics (2013)
An integrated encyclopedia of DNA elements in the human genome
Ian Dunham et al.
NATURE (2012)
Oncolytic virotherapy
Stephen J. Russell et al.
NATURE BIOTECHNOLOGY (2012)
Inflammatory signaling compromises cell responses to interferon alpha
W-C HuangFu et al.
ONCOGENE (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
A diverse range of gene products are effectors of the type I interferon antiviral response
John W. Schoggins et al.
NATURE (2011)
Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5
Hiroki Kato et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Adjuvant therapy of melanoma with interferon: lessons of the past decade
Paolo A. Ascierto et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity
Yueh-Ming Loo et al.
JOURNAL OF VIROLOGY (2008)
Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity
HM Chang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents
DF Stojdl et al.
CANCER CELL (2003)
PANTHER: A library of protein families and subfamilies indexed by function
PD Thomas et al.
GENOME RESEARCH (2003)
Epigenetic silencing of multiple interferon pathway genes after cellular immortalization
OI Kulaeva et al.
ONCOGENE (2003)
mda-5:: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties
DC Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
